Monoclonal Antibodies: A Designer COVID-19 Treatment Requires Designer Rehabilitation
Monoclonal antibodies aren’t new. While we may currently be using them experimentally to treat patients in the early phases of COVID-19 infection, they have been around since 1985. You may already be familiar with a…